Your browser doesn't support javascript.
loading
Dental consensus on HSCT - Part II: dental Care during HSCT.
Gobbi, Marcella Ferreira; Ferreira, Mariana Henriques; de Carvalho, Danielle Lima Corrêa; Silva, Geisa Badauy Lauria; Macari, Karina Silva Moreira; Neves, Lilian de Jesus; Santos, Paulo Sérgio da Silva; Junior, Luiz Alberto Valente Soares; Melo, Walmyr Ribeiro; Antunes, Héliton Spíndola; De Macedo, Leandro Dorigan; Eduardo, Fernanda de Paula; Bezinelli, Leticia Mello.
Afiliación
  • Gobbi MF; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Ferreira MH; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • de Carvalho DLC; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Silva GBL; Serviço de Odontologia do Hospital Aráujo Jorge/Associação de Combate ao Câncer em Goiás, Goiânia, Goiás, Brazil.
  • Macari KSM; Departamento de Odontologia, Hospital de Câncer Infantojuvenil de Barretos do Hospital de Amor, Barretos, SP, Brazil.
  • Neves LJ; Departamento de Odontologia, Hospital de Câncer Infantojuvenil de Barretos do Hospital de Amor, Barretos, SP, Brazil.
  • Santos PSDS; Departamento de Cirurgia, Estomatologia, Patologia e Radiologia da Faculdade de Odontologia de Bauru, Universidade de São Paulo, Bauru, Brazil.
  • Junior LAVS; Divisão de Odontologia Instituto Central, Hospital das Clínicas da Faculdade de Medicina-USP.
  • Melo WR; Hospital Samaritano Higienópolis.
  • Antunes HS; Divisão de Pesquisa Clínica, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.
  • De Macedo LD; Serviço de Odontologia e Estomatologia do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Brazil; Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Brazil.
  • Eduardo FP; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Bezinelli LM; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. Electronic address: leticia.bezinelli@einstein.br.
Hematol Transfus Cell Ther ; 45(3): 368-378, 2023.
Article en En | MEDLINE | ID: mdl-37321878
ABSTRACT
During the state of immune vulnerability in hematopoietic stem cell transplantation (HSCT), the patient has an increased risk of developing a vast number of complications, including severe problems in the oral cavity. These situations require professional oral care to act in the diagnosis and treatment of these conditions, as well as to develop prevention protocols to minimize patient's complications. Oral mucositis, opportunistic infections, bleeding, specific microbiota, taste, and salivary alterations are complications that can occur during HSCT and interfere with various aspects, such as pain control, oral intake, nutrition, bacteremia and sepsis, days of hospitalization and morbidity. Several guidelines have been published to address the role of professional oral care during the HSCT, we describe a consensus regarding these recommendations.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Hematol Transfus Cell Ther Año: 2023 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Hematol Transfus Cell Ther Año: 2023 Tipo del documento: Article País de afiliación: Brasil